Cargando…

Apolipoprotein E polymorphisms contribute to statin response in Chinese ASCVD patients with dyslipidemia

BACKGROUND: Apolipoprotein E (ApoE) plays an important role in lipid metabolism and clearance. Statins are the most common drugs used to modulate the lipid profile in the clinic therapy; the associations between ApoE polymorphisms and statin response to lipids were inconsistent in previous studies a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lei, He, Siying, Li, Zuhua, Gan, Xuedong, Li, Siwei, Cheng, Xiaohuan, Yang, Na, Zheng, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545221/ https://www.ncbi.nlm.nih.gov/pubmed/31153375 http://dx.doi.org/10.1186/s12944-019-1069-5

Ejemplares similares

Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment
por: Begcevic Brkovic, Ilijana, et al.
Publicado: (2022)

Expanding statin use for prevention of ASCVD in Indians: Reasoned and simplified proposals
por: Enas, Enas A., et al.
Publicado: (2020)

Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
por: Armstrong, Shannon O, et al.
Publicado: (2019)

Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
por: Dansinger, Michael L., et al.
Publicado: (2019)

Apolipoprotein B Gene Polymorphisms and Dyslipidemia in HIV Infected Adult Zimbabweans
por: Kodogo, Vitaris, et al.
Publicado: (2016)

Highlights in ASCVD Primary Prevention for 2021
por: Polonsky, Tamar S., et al.
Publicado: (2022)

Association of Apolipoprotein E Gene Polymorphism with Type 2 Diabetic Nephropathy in the Southern Chinese Population
por: Gan, Caiyan, et al.
Publicado: (2023)

Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka and Homozygous Apolipoprotein E2/2 without Dyslipidemia, with Characteristic Electron-Dense Deposits
por: Koshino, Akihiko, et al.
Publicado: (2022)

Apolipoprotein E polymorphism and the risk of intracranial aneurysms in a Chinese population
por: Liu, Hao, et al.
Publicado: (2016)

Apolipoprotein E Gene Polymorphisms Are Associated with Primary Hyperuricemia in a Chinese Population
por: Wu, Jie, et al.
Publicado: (2014)

Association of Apolipoprotein E Polymorphisms with White Matter Lesions and Brain Atrophy
por: Niu, ZhiLi, et al.
Publicado: (2020)

Gauging ASCVD Risk, Does Race Matter?
por: Zuo, Ming-Liang, et al.
Publicado: (2022)

Health Literacy is Essential to ASCVD Prevention in Youth
por: Mann, Harnoor K., et al.
Publicado: (2023)

Association of hyperuricemia combined with sarcopenia on ASCVD risk
por: Nie, Guqiao, et al.
Publicado: (2023)

The role of dyslipidemia and statins in venous thromboembolism
por: Ray, Joel G, et al.
Publicado: (2001)

Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
por: Johnson, Lance A., et al.
Publicado: (2011)

Association of Apolipoprotein E Gene Polymorphism with Ischemic Stroke in Coronary Heart Disease Patients Treated with Medium-intensity Statins
por: Lv, Ping, et al.
Publicado: (2020)

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia
por: Vanwong, Natchaya, et al.
Publicado: (2022)

Association of Apolipoprotein E Polymorphisms and Risks of Ischemic Stroke in Chinese Patients with Type 2 Diabetes Mellitus
por: Wang, Na, et al.
Publicado: (2021)

New Drugs for Treating Dyslipidemia: Beyond Statins
por: Ahn, Chang Ho, et al.
Publicado: (2015)

Chinese ASCVD risk equations rather than pooled cohort equations are better to identify macro- and microcirculation abnormalities
por: Li, Qiaowei, et al.
Publicado: (2020)

Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population
por: Yu, Mingxi, et al.
Publicado: (2015)

Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis
por: Liu, Mengying, et al.
Publicado: (2014)

Apolipoprotein E polymorphisms and primary glaucoma in Saudis
por: Al-Dabbagh, Najwa Mohammed, et al.
Publicado: (2009)

Association of the lipoprotein lipase and Apolipoprotein C-II gene polymorphisms with risk of dyslipidemia in smokers and non-smokers male
por: Al-Samawi, Rithab Ibrahim, et al.
Publicado: (2022)

Prevalence and types of persistent dyslipidemia in patients treated with statins
por: Reiner, Željko, et al.
Publicado: (2013)

The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Protects against Dyslipidemia-Related Kidney Injury in Apolipoprotein E Knockout Mice
por: Li, Jingjing, et al.
Publicado: (2014)

Apolipoprotein E polymorphisms increase the risk of post-stroke depression
por: Li, Xue-bin, et al.
Publicado: (2016)

Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
por: Azar, Sami T, et al.
Publicado: (2014)

Chronic environmental circadian disruption increases atherosclerosis and dyslipidemia in female, but not male, ApolipoproteinE-deficient mice
por: Chalfant, Jeffrey M., et al.
Publicado: (2023)

MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population
por: Xu, Xiaoyi, et al.
Publicado: (2023)

Combination of Endoglin and ASCVD Risk Assessment Improves Carotid Subclinical Atherosclerosis Recognition
por: Li, Qiaowei, et al.
Publicado: (2020)

Apolipoprotein E gene polymorphism and renal function are associated with apolipoprotein E concentration in patients with chronic kidney disease
por: Czaplińska, Monika, et al.
Publicado: (2019)

The apolipoprotein E polymorphism and the cholesterol-raising effect of coffee
por: Strandhagen, Elisabeth, et al.
Publicado: (2004)

Apolipoprotein E-polymorphism, frailty and mortality in older adults
por: Rockwood, Kenneth, et al.
Publicado: (2008)

Association between Alzheimer’s Disease and Apolipoprotein E Polymorphisms
por: Gozalpour, E, et al.
Publicado: (2010)

ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISMS AND EPILEPSY IN CHILDREN
por: Kukuruzović, Monika, et al.
Publicado: (2021)

Estimated ASCVD risk according to statin use in US adults with borderline triglycerides: Results from National Health and Nutrition Examination Survey (NHANES) 2007–2014
por: Fan, Wenjun, et al.
Publicado: (2020)

Apolipoprotein Mimetic Peptides: An Emerging Therapy against Diabetic Inflammation and Dyslipidemia
por: Wolkowicz, Paul, et al.
Publicado: (2021)

The Potential Role of Biomarkers Associated with ASCVD Risk: Risk-Enhancing Biomarkers
por: Choi, Seonghoon
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hcj12gqi75mnj2u2jv7ils3591